The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Prof. Mark Lawler (CDDF Board) & his colleagues in the Lancet Oncology European Groundshot Commission on cancer research have published an insightful article on 16 November 2022.

The European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission highlights the need to pick up the pace on cancer research in Europe.In this Commission, Prof. Mark Lawler and colleagues describe challenges for cancer research in Europe, including difficulties in implementation, poor infrastructure, and lack of real-world data. The authors also provide new analysis on disparities between and within countries in Europe in terms of survival, and research activity, output, and funding, advocating for a pan-European approach to overcome this issue.

To read the full text: https://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(22)00540-X.pdf

To listen to the podcast: https://www.thelancet.com/commissions/European-Groundshot-cancer-research?dgcid=raven_jbs_etoc_feature_lanoncgroundshot22

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

Privacy Policy

info@cddf.org
Tel: +32 2 880 62 70